These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3722891)

  • 1. Breeding water and mosquito strain as factors influencing susceptibility of Culex pipiens L. to Bacillus thuringiensis serotype H-14.
    Abou Bakr H; el-Husseini MM; Merdan AI
    J Egypt Soc Parasitol; 1986 Jun; 16(1):235-41. PubMed ID: 3722891
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual activity of Bacillus thuringiensis serovars medellin and jegathesan on Culex pipiens and Aedes aegypti larvae.
    Thiéry I; Fouque F; Gaven B; Lagneau C
    J Am Mosq Control Assoc; 1999 Sep; 15(3):371-9. PubMed ID: 10480130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bacillus sphaericus and Bacillus thuringiensis on acid-phosphatase activity of mosquito larvae, Culex pipiens and Aedes caspius.
    Hussein MA; Hafez JA
    J Egypt Soc Parasitol; 1989 Jun; 19(1):195-203. PubMed ID: 2565356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Settling of larvicidal material in Bacillus thuringiensis israelensis serotype H-14 formulations sprayed on water surface.
    el-Husseini MM; Merdan AI; Abou Bakr H
    J Egypt Soc Parasitol; 1986 Jun; 16(1):243-7. PubMed ID: 3722892
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of mosquito-pathogenic Bacillus sphaericus & B. thuringiensis from the root surface of hydrophytes.
    Manonmani AM; Rajendran G; Balaraman K
    Indian J Med Res; 1991 Mar; 93():111-4. PubMed ID: 1855819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of certain formulations of the bacterial larvicide, Bacillus thuringiensis, serotype H-14 on Culex pipiens L. in Egypt.
    Merdan AI; el-Husseni MM; Abu-Bakr H; Rady MM
    J Egypt Soc Parasitol; 1991 Aug; 21(2):403-10. PubMed ID: 1875070
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of Bacillus sphaericus and Bacillus thuringiensis var. israelensis for control of Culex pipiens and floodwater Aedes larvae in Iowa.
    Berry WJ; Novak MG; Khounlo S; Rowley WA; Melchior GL
    J Am Mosq Control Assoc; 1987 Dec; 3(4):579-82. PubMed ID: 3504943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Bacillus thuringiensis serotype H-14 on certain Egyptian mosquito species in small ditches.
    Merdan AI; Hilmy NM; Ibrahim AA
    J Egypt Soc Parasitol; 1986 Jun; 16(1):171-83. PubMed ID: 2873191
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory trials with Bacillus thuringiensis serotype H-14 in controlling mosquito larvae.
    Bekheit SS
    J Egypt Soc Parasitol; 1984 Jun; 14(1):71-6. PubMed ID: 6145746
    [No Abstract]   [Full Text] [Related]  

  • 10. The utilization of bacilli as larvicidal agents against anopheline and culicine mosquitoes in Turkey. I. Larvicidal activity of Bacillus thuringiensis serotype H-14.
    Matur A; Ceber K
    J Trop Med Hyg; 1988 Oct; 91(5):229-30. PubMed ID: 3184242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a cry4Ba-type gene of Bacillus thuringiensis israelensis and evidence of the synergistic larvicidal activity of its encoded protein with Cry2A delta-endotoxin of B. thuringiensis kurstaki on Culex pipiens (common house mosquito).
    Zghal RZ; Tounsi S; Jaoua S
    Biotechnol Appl Biochem; 2006 Apr; 44(Pt 1):19-25. PubMed ID: 16309381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field tests of Bacillus thuringiensis var. israelensis against Culex mosquito larvae in Dhaka City.
    Ahmed TU; Maheswary NP; Ahmed AJ; Ahmed JU
    Bangladesh Med Res Counc Bull; 1988 Dec; 14(2):58-66. PubMed ID: 3250457
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors influencing the activity of Bacillus thuringiensis var. israelensis treatments.
    Becker N; Zgomba M; Ludwig M; Petric D; Rettich F
    J Am Mosq Control Assoc; 1992 Sep; 8(3):285-9. PubMed ID: 1357088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Czechoslovak and Soviet Bacillus thuringiensis (serotype H-14) formulations against mosquito larvae.
    Rettich F
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):53-63. PubMed ID: 2883232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary field evaluation of a Malaysian isolate of Bacillus thuringiensis serotype H-14 against Culex pseudovishnui.
    Lee HL; Seleena P
    Southeast Asian J Trop Med Public Health; 1990 Mar; 21(1):143-4. PubMed ID: 2402673
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibacteriophage action on the larvicidal activity of Bacillus thuringiensis H-14 and Bacillus sphaericus against Culex pipiens.
    Rady MH; Saleh MB; Merdan AI
    J Egypt Public Health Assoc; 1990; 65(3-4):319-34. PubMed ID: 2133905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of bactoculicide (Bacillus thuringiensis H-14) for controlling mosquito breeding in industrial scrap at BHEL, Hardwar (U.P.).
    Dua VK; Sharma SK; Sharma VP
    Indian J Malariol; 1993 Mar; 30(1):17-21. PubMed ID: 8100539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field trials with Vectolex (Bacillus sphaericus) and Vectobac (Bacillus thuringiensis (H-14)) against Anopheles gambiae and Culex quinquefasciatus breeding in Zaire.
    Karch S; Manzambi ZA; Salaun JJ
    J Am Mosq Control Assoc; 1991 Jun; 7(2):176-9. PubMed ID: 1895075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a flowable concentrate formulation of Bacillus thuringiensis (H-14) against larval mosquitoes in southern Iran.
    Zaim M; Kasiri H; Motabar M
    J Am Mosq Control Assoc; 1992 Jun; 8(2):156-8. PubMed ID: 1279118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioassay of some Egyptian isolates of Bacillus thuringiensis against Culex pipiens (Diptera: Culicidae).
    Zayed ME; Bream AS
    Commun Agric Appl Biol Sci; 2004; 69(3):219-28. PubMed ID: 15759417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.